Literature DB >> 1723393

Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell.

S E Kahn1, W Y Fujimoto, D A D'Alessio, J W Ensinck, D Porte.   

Abstract

Islet amyloid polypeptide (IAPP) has been shown to be actively secreted by the pancreatic B-cell along with insulin. To determine whether the modulation of B-cell IAPP secretion is similar to that of insulin, we assessed IAPP release in response to glucose at 4 different concentrations (1.67, 5.5, 8.8 and 16.7 mM) and to non-glucose secretagogues at different glucose concentrations in a neonatal rat islet monolayer culture preparation. Glucose alone stimulated IAPP and insulin secretion in a dose dependent fashion with maximal release for both peptides occurring at 8.8 mM. B-cell secretion of IAPP in response to arginine, isobutylmethylxanthine or both together was potentiated by increasing glucose concentrations from 1.67 to 16.7 mM. This same pattern of glucose potentiation was observed for insulin secretion. The data indicate that the pattern of peptide responses of cultured neonatal B-cells to glucose is similar for both IAPP and insulin release. Furthermore, the data suggest that glucose is capable of potentiating B-cell secretion of both IAPP and insulin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723393     DOI: 10.1055/s-2007-1003759

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

Review 1.  Type 2 diabetes as a protein misfolding disease.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Peter C Butler; Claudio Soto
Journal:  Trends Mol Med       Date:  2015-05-18       Impact factor: 11.951

2.  Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.

Authors:  O G Kolterman; S Schwartz; C Corder; B Levy; L Klaff; J Peterson; A Gottlieb
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

3.  Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway.

Authors:  S E Kahn; C B Verchere; D A D'Alessio; D L Cook; W Y Fujimoto
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

4.  Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation.

Authors:  Sakeneh Zraika; Kathryn Aston-Mourney; Peter Marek; Rebecca L Hull; Pattie S Green; Jayalakshmi Udayasankar; Shoba L Subramanian; Daniel P Raleigh; Steven E Kahn
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

5.  Role of islet amyloid polypeptide secretion in insulin-resistant humans.

Authors:  A Kautzky-Willer; K Thomaseth; G Pacini; M Clodi; B Ludvik; C Streli; W Waldhäusl; R Prager
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

Review 6.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

7.  Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro.

Authors:  C B Verchere; D A D'Alessio; R D Palmiter; S E Kahn
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

8.  High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus.

Authors:  Johan F Paulsson; Johnny Ludvigsson; Annelie Carlsson; Rosaura Casas; Gun Forsander; Sten A Ivarsson; Ingrid Kockum; Åke Lernmark; Claude Marcus; Bengt Lindblad; Gunilla T Westermark
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

Review 9.  Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease.

Authors:  Ana F Raimundo; Sofia Ferreira; Ivo C Martins; Regina Menezes
Journal:  Front Mol Neurosci       Date:  2020-03-20       Impact factor: 5.639

Review 10.  Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes.

Authors:  Ana F Raimundo; Sofia Ferreira; Francisco A Tomás-Barberán; Claudia N Santos; Regina Menezes
Journal:  Nutrients       Date:  2021-11-27       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.